Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains isoflavones (daidzein and genistein) derived from soy and palmitoylethanolamide (PEA), a naturally occurring fatty acid amide. The intended use is generally for managing inflammatory conditions and pain.
## Primary Indications
This combination is most commonly marketed and studied for:
* Pain management, particularly neuropathic pain.
* Inflammatory conditions.
## Adult Dosing
Dosing for this combination product varies significantly between commercially available formulations. A common dosage range for PEA is 300-600 mg twice daily, and for isoflavones (genistein and daidzein) it can range from 50-100 mg daily. Always refer to the specific product labeling for precise dosing recommendations.
## Pediatric Dosing
There is insufficient established pediatric dosing for this specific combination product. Use in pediatric populations is generally not recommended without expert consultation and robust clinical evidence.
## Dose Adjustments
No specific dose adjustments are established for renal or hepatic impairment due to a lack of data. Dosing is typically based on product formulation and clinical response.
## Contraindications
* Known hypersensitivity to any component of the formulation.
* Pregnancy and breastfeeding (due to lack of safety data and potential hormonal effects of isoflavones).
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal discomfort.
* **Other:** Dizziness, headache, fatigue.
* Isoflavones may have mild estrogenic effects; long-term use in hormone-sensitive conditions warrants caution.
## Key Drug Interactions
* **Phytoestrogens (Genistein, Daidzein):** May interact with hormone replacement therapy (HRT) or other estrogen-acting medications. Theoretically, may affect thyroid hormone levels; monitor thyroid function if clinically indicated.
* **PEA:** Generally considered to have a low potential for drug interactions.
## Monitoring
* Monitor for efficacy in pain and inflammation reduction.
* Monitor for adverse effects, particularly gastrointestinal upset.
* Consider monitoring thyroid function and hormone-sensitive markers if long-term use or high-dose isoflavones are involved, though this is not routinely recommended.
## Clinical Pearls
* The efficacy of this combination is based on its individual components, with PEA acting as an endocannabinoid-like modulator and isoflavones having anti-inflammatory and antioxidant properties.
* Individual responses can vary significantly.
* Ensure patients are aware that these are supplements and may not have the same regulatory oversight as prescription medications.
***
**Disclaimer:** This information is intended for clinical decision support and is not a substitute for professional medical advice. Always consult the most current prescribing information or official guidelines and exercise clinical judgment. Verify dosing and safety information with the specific product manufacturer's labeling and current literature before administration.
